Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial J Shapiro, JJB Van Lanschot, MCCM Hulshof, P van Hagen, ... The lancet oncology 16 (9), 1090-1098, 2015 | 2345 | 2015 |
Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial BM Eyck, JJB van Lanschot, MCCM Hulshof, BJ van der Wilk, J Shapiro, ... Journal of Clinical Oncology 39 (18), 1995-2004, 2021 | 387 | 2021 |
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study BJ Noordman, MCW Spaander, R Valkema, BPL Wijnhoven, ... The Lancet Oncology 19 (7), 965-974, 2018 | 240 | 2018 |
Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A M Pulvino, Y Liang, D Oleksyn, M DeRan, E Van Pelt, J Shapiro, I Sanz, ... Blood, The Journal of the American Society of Hematology 120 (8), 1668-1677, 2012 | 181 | 2012 |
Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival AK Talsma, J Shapiro, CWN Looman, P van Hagen, EW Steyerberg, ... Annals of surgery 260 (5), 786-793, 2014 | 160 | 2014 |
A clinicopathologic study of 42 patients with granulomatous gastritis: is there really an “idiopathic” granulomatous gastritis? JL Shapiro, JR Goldblum, RE Petras The American journal of surgical pathology 20 (4), 462-470, 1996 | 127 | 1996 |
Encoding of whisker input by cerebellar Purkinje cells LWJ Bosman, SKE Koekkoek, J Shapiro, BFM Rijken, F Zandstra, ... The Journal of physiology 588 (19), 3757-3783, 2010 | 117 | 2010 |
Sarcopenia/muscle mass is not a prognostic factor for short‐and long‐term outcome after esophagectomy for cancer BA Grotenhuis, J Shapiro, S Van Adrichem, M de Vries, M Koek, ... World journal of surgery 40 (11), 2698-2704, 2016 | 116 | 2016 |
Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer J Shapiro, P Van Hagen, HF Lingsma, BPL Wijnhoven, K Biermann, ... Annals of surgery 260 (5), 807-814, 2014 | 100 | 2014 |
Accuracy of detecting residual disease after cross neoadjuvant chemoradiotherapy for esophageal cancer (preSANO Trial): rationale and protocol BJ Noordman, J Shapiro, MCW Spaander, KK Krishnadath, ... JMIR research protocols 4 (2), e4320, 2015 | 87 | 2015 |
Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma CAJ Ong, J Shapiro, KS Nason, JM Davison, X Liu, C Ross-Innes, ... Journal of clinical oncology 31 (12), 1576, 2013 | 83 | 2013 |
Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa J Shapiro, FJW ten Kate, P van Hagen, K Biermann, BPL Wijnhoven, ... Annals of Surgery 258 (5), 678-689, 2013 | 79 | 2013 |
Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically JL Frater, KF McCarron, JP Hammel, JL Shapiro, ML Miller, RR Tubbs, ... American journal of clinical pathology 116 (5), 655-664, 2001 | 71 | 2001 |
Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial BJ Noordman, MGE Verdam, SM Lagarde, J Shapiro, M Hulshof, ... Annals of Oncology 29 (2), 445-451, 2018 | 70 | 2018 |
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy A Zeidan, R Sham, J Shapiro, A Baratta, P Kouides Leukemia & lymphoma 48 (7), 1410-1413, 2007 | 57 | 2007 |
Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline M Pulvino, L Chen, D Oleksyn, J Li, G Compitello, R Rossi, S Spence, ... Oncotarget 6 (17), 14796, 2015 | 48 | 2015 |
Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer ELA Toxopeus, D Nieboer, J Shapiro, K Biermann, A van der Gaast, ... Radiotherapy and Oncology 115 (3), 392-398, 2015 | 42 | 2015 |
Patients' preferences for treatment after neoadjuvant chemoradiotherapy for oesophageal cancer BJ Noordman, EW de Bekker-Grob, P Coene, E van der Harst, ... Journal of British Surgery 105 (12), 1630-1638, 2018 | 41 | 2018 |
Prognostic value of pretreatment pathological tumor extent in patients treated with neoadjuvant chemoradiotherapy plus surgery for esophageal or junctional cancer J Shapiro, K Biermann, D van Klaveren, GJA Offerhaus, FJW Ten Kate, ... Annals of surgery 265 (2), 356-362, 2017 | 38 | 2017 |
CD5− B-Cell Lymphoproliferative Disorders Presenting in Blood and Bone Marrow: A Clinicopathologic Study of 40 Patients JL Shapiro, ML Miller, B Pohlman, E Mascha, AJ Fishleder American journal of clinical pathology 111 (4), 477-487, 1999 | 36 | 1999 |